One of the great aspects of the Medicare Shared Savings Program is that it provides an important opportunity directly to physicians, said Louis Morgenier, chief executive officer of Physicians ACO, LLC.
One of the great aspects of the Medicare Shared Savings Program is that it provides an important opportunity directly to physicians, said Louis Morgenier, chief executive officer of Physicians ACO, LLC.
Transcript (slightly modified for readability)
What have we learned from the Medicare Shared Savings Program so far?
It’s a great program and Medicare is making great strides in introducing it across the country. I think with this round of applications there will be something like 660 ACOs. At last count I think there were 440 last year with some 20% of Medicare beneficiaries being assigned to ACOs and the head of Medicare says there should be 50% of Medicare beneficiaries assigned to an ACO by 2018, which I think is an incredible accomplishment by CMS.
I think that they’re giving directly to physicians a great opportunity, particularly to primary care physicians, to help to control the costs of patient expenditures for Medicare fee-for-service and it’s nice that they’re not giving it to some Wall Street company or to some insurance company. They’re giving the opportunity directly to physicians. For example, some of them I’ve put together, they have a total benchmark of a couple hundred million dollars, and we have say 12,000 or 15,000 patients. And Medicare is just giving us that business and handing it to us on our lap. It’s really a phenomenal opportunity.
Furthermore, it’s only one-sided risk to get started if you’d like to. I think it’s a great opportunity so that if you save money, you can get half of it. Of course, you know if you hit quality measures on your second year and things such as that. But overall I think it’s a really great opportunity.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More